The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.
|Translated title of the contribution||Conversion from conventional to atypical neuroleptics: recommendations for inpatient and outpatient treatment|
|Number of pages||17|
|Publication status||Published - 2000|
- Atypical antipsychotics
- Conventional antipsychotics